{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:14:53Z","timestamp":1778130893851,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n X-linked Alport syndrome (XLAS) is a disorder of type IV collagen structure caused by pathogenic variants of the COL4A5 gene and characterized by progressive kidney disease, hearing loss, and ocular abnormalities. Although mutation screening is commonly performed for AS-associated genes, transcriptional analysis is not a standard test for patients with XLAS, and the functional consequences of splicing abnormalities caused by intronic variants are rarely studied.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this study, nine family members from a three-generation pedigree in Gansu Province, China, were investigated. We used targeted next-generation sequencing to identify genetic variants in family members, confirmed the mutation site by Sanger sequencing, and predicted the pathogenicity of the variant using bioinformatics software. The splicing effects of the mutation were analyzed using minigene testing with HEK 293T cells, and further confirmed by\n in vivo<\/jats:italic>\n transcript analysis using RNA extracted from the proband\u2019s skin cells.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The proband was a 5-year-old male child who presented with microhematuria at the age of 4.5 years. Four relatives in this pedigree had a family history of kidney disease, all presenting with microhematuria with or without proteinuria. The proband\u2019s elder brother and maternal uncle had progressed to kidney failure. Immunofluorescence staining of the proband\u2019s epidermal basement membrane showed negative expression of the \u03b15 chain. A novel splice variant (c.1587+4A&gt;G) was identified in intron 23 of COL4A5 among the affected family members. Sanger sequencing confirmed that this variant co-segregated with the disease phenotype. In silico analysis predicted that this variant may cause abnormal splicing. Transcript analysis of the proband\u2019s skin tissue and minigene assay demonstrated that the variant causes abnormal mRNA splicing and exon 23 skipping, leading to a frameshift, premature termination codon, and predicted nonsense-mediated mRNA decay.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n The study identified a novel intronic variant (c.1587+4A&gt;G) in the COL4A5 gene in a Chinese family with XLAS, and functional experiments verified that this variant induces aberrant splicing. This study highlights the importance of transcript analysis for intronic variants and further expands the mutational spectrum of COL4A5 in XLAS.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2026.1783004","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:56:07Z","timestamp":1778129767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and pathogenicity analysis of a novel intronic COL4A5 variant in a Chinese family"],"prefix":"10.3389","volume":"13","author":[{"given":"Pei","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Nephrology, Xi\u2019an Children\u2019s Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-mei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xi\u2019an Children\u2019s Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Suo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xi\u2019an Children\u2019s Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xi\u2019an Children\u2019s Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xi\u2019an Children\u2019s Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xi\u2019an Children\u2019s Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","article-title":"A review of clinical characteristics and genetic backgrounds in Alport syndrome","volume":"23","author":"Nozu","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3\u2013COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1038\/s41598-025-92520-9","article-title":"Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese","volume":"15","author":"Lim","year":"2025","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","article-title":"Genotype-phenotype correlation in X-linked Alport syndrome","volume":"21","author":"Bekheirnia","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1681\/ASN.2018030228","article-title":"Detection of splicing abnormalities and genotype-phenotype correlation in X-linked Alport syndrome","volume":"29","author":"Horinouchi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"841391","DOI":"10.3389\/fmed.2022.841391","article-title":"The contribution of COL4A5 splicing variants to the pathogenesis of X-linked Alport syndrome","volume":"9","author":"Yamamura","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","article-title":"Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome","volume":"98","author":"Yamamura","year":"2020","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease'","volume":"84","author":"Andrassy","year":"2013","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1681\/ASN.V981433","article-title":"Comparison of \u03b15(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome","volume":"9","author":"Nakanishi","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"865034","DOI":"10.3389\/fmed.2022.865034","article-title":"Genotype-phenotype correlations for pathogenic COL4A3-COL4A5 variants in X-linked, autosomal recessive, and autosomal dominant Alport syndrome","volume":"9","author":"Savige","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0178630","DOI":"10.1371\/journal.pone.0178630","article-title":"Alport syndrome cold cases: missing mutations identified by exome sequencing and functional analysis","volume":"12","author":"Chiereghin","year":"2017","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1046\/j.1523-1755.2003.00251.x","article-title":"Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of kidney disease","volume":"64","author":"Massella","year":"2003","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1523-1755.2005.00204.x","article-title":"Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts","volume":"67","author":"Wang","year":"2005","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1093\/ndt\/gfac002","article-title":"Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome","volume":"37","author":"Di","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.00580116","article-title":"Alport syndrome in women and girls","volume":"11","author":"Savige","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1009188","DOI":"10.3389\/fped.2022.1009188","article-title":"A deep intronic splice variant of the COL4A5 gene in a Chinese family with X-linked Alport syndrome","volume":"10","author":"Qian","year":"2023","journal-title":"Front Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41467-020-16605-x","article-title":"Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5","volume":"11","author":"Yamamura","year":"2020","journal-title":"Nat Commun"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1783004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:56:08Z","timestamp":1778129768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1783004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":20,"alternative-id":["10.3389\/fmed.2026.1783004"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1783004","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1783004"}}